TheEdgeResearch
Home / Stocks / EEVVF

Eve & Co Incorporated (EEVVF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.08 ▲ +0.00%
Market Cap
$2.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.60
52-Wk Range
0.074-0.122
CEO
Melinda Rombouts
Country
CA
Currency
USD

Eve & Co Incorporated operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Strathroy, ON, CA. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $2.9M. On trailing twelve-month figures it carries a trailing P/E of -0.29, a net margin of -287.9%. Its beta of 0.60 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.29
Price / Sales
1066.10
Price / Book
0.12
EV / EBITDA
-426.42
Gross margin
-79.6%
Operating margin
-266.8%
Net margin
-287.9%
Return on equity
Debt / equity
0.00
Current ratio
0.42
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2021-01-08
Headquarters
Strathroy, ON, CA
About Eve & Co Incorporated

Eve & Co Incorporated operates within Canada, utilizing its subsidiary, Natural MedCo Ltd., to cultivate and distribute a range of cannabis products, including dried cannabis, live plants, and cannabis oil. The company particularly focuses on the female market through its dedicated EVE brand. Its corporate headquarters are situated in Strathroy, Canada.

Comparable companies

Eve & Co Incorporated is most often compared with the following Healthcare names:

ATIPAWKNFCBDNFCIMVFDLTNFGABLFHERTFNHPHFOCTHFRVLWF
More research on EEVVF
EEVVF technical analysis EEVVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →